It may seem counter-intuitive, a potentially powerful
treatment for breast cancer based on blocking receptors for the male
hormone androgen; but that’s what turns out to be the case. Researchers
at the University of Colorado Cancer Center recently completed a Phase I
clinical trial of Enzalutamide, which provided evidence of the safety
and possible effectiveness of the approach.